Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 249 entries
View as:

PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study

Phase: N/A Priority: Normal
NCT ID: NCT04535739 Org: User:
Start: 07/01/19 End: 06/30/22 Due: 06/30/23

A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01285219 Org: User:
Start: 01/31/06 End: 12/31/08 Due: 12/31/09

Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC

Phase: N/A Priority: Normal
NCT ID: NCT05343117 Org: User:
Start: 12/01/21 End: 06/01/24 Due: 06/01/25

FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage

Phase: N/A Priority: Normal
NCT ID: NCT05279677 Org: User:
Start: 08/12/22 End: 04/30/24 Due: 04/30/25

Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02446574 Org: User:
Start: 07/31/07 End: 12/31/16 Due: 12/31/17

Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04289974 Org: User:
Start: 02/14/19 End: 04/30/22 Due: 04/30/23

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC

Phase: N/A Priority: Normal
NCT ID: NCT02688036 Org: User:
Start: 02/29/16 End: 05/31/20 Due: 05/31/21

TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03916913 Org: User:
Start: 01/01/19 End: 01/01/23 Due: 01/01/24

The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV)

Phase: N/A Priority: Normal
NCT ID: NCT01056705 Org: User:
Start: 07/31/09 End: 08/31/10 Due: 08/31/11

Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05484024 Org: User:
Start: 08/06/22 End: 07/31/30 Due: 07/31/31

Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02675088 Org: User:
Start: 12/01/17 End: 12/31/19 Due: 12/31/20

Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02765373 Org: User:
Start: 01/31/15 End: - Due: -

Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03320421 Org: User:
Start: 01/01/17 End: 01/01/19 Due: 01/01/20

A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast

Phase: N/A Priority: Normal
NCT ID: NCT03047889 Org: User:
Start: 04/30/16 End: 12/31/17 Due: 12/31/18

Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03731442 Org: User:
Start: 11/01/18 End: 10/31/27 Due: 10/31/28

A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04247984 Org: User:
Start: 05/01/18 End: 01/31/22 Due: 01/31/23

Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection

Phase: N/A Priority: Normal
NCT ID: NCT04762459 Org: User:
Start: 08/01/21 End: 05/31/29 Due: 05/31/30

Sintilimab Plus R-CHOP as the First-line Treatment in Patients With Diffuse Large B-Cell Lymphoma.

Phase: N/A Priority: Normal
NCT ID: NCT04023916 Org: User:
Start: 12/01/19 End: 07/30/21 Due: 07/30/22

Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT01503385 Org: User:
Start: 12/31/11 End: 12/31/16 Due: 12/31/17

Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China

Phase: N/A Priority: Normal
NCT ID: NCT05194371 Org: User:
Start: 06/01/21 End: 12/15/21 Due: 12/15/22

Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01143974 Org: User:
Start: 06/30/10 End: 06/30/12 Due: 06/30/13

Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04140318 Org: User:
Start: 11/15/19 End: 02/01/23 Due: 02/01/24

Safety and Preliminary Immunogenicity Study of Inactivated Vaccine for Prevention of Rotavirus Infection

Phase: N/A Priority: Normal
NCT ID: NCT04626856 Org: User:
Start: 12/03/20 End: 08/31/21 Due: 08/31/22

Optical Assessment on Brain Death Via a Oxygen Supply Procedure

Phase: N/A Priority: Normal
NCT ID: NCT03864887 Org: User:
Start: 02/11/19 End: 12/31/19 Due: 12/31/20

Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04275986 Org: User:
Start: 01/20/20 End: 03/31/24 Due: 03/31/25